Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16675781 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment
Condition: Tuberculosis, Pulmonary
Intervention: Drug: moxifloxacin (with isoniazid, rifampin, pyrazinamide)

Indicates status has not been verified in more than two years